British researchers have conducted a ground-breaking trial of a new cancer drug that has shown promise, with many patients experiencing remission for extended periods. The experimental research, by the team at the Christie NHS Foundation Trust in Manchester, UK, focused on blood cancers like myeloma. 

The results showed the majority of participants responding positively to treatment and people going into remission for months and years.